Biden Admin’s Last Part D Rule Also Has Generic Drug Exclusion Comments, Prescription Payment Plan Tweaks

In the proposed rule, CMS said it would begin reviewing Part D plan formularies and utilization practices to see if programs include incentives to reduce costs, as well as offered suggestions for implementing the new Medicare Prescription Payment Plan.

More changes are expected to the M3P plan due to its operational complexity. (Shutterstock)

More from Medicare

More from Market Access